This inventor holds 12 USPTO granted patents and 11 published patent applications, plus 1 CIPO patent and 8 EPO patents. Top assignees: Biomarin Pharmaceutical Inc., Mirum Pharmaceuticals, Inc., Merck Eprova Ag. Active years: 2009-2026.
Company Filing History:
7 out of 136 
5 out of 6 
1 out of 6 Years Active: 2009-2026
Title: Alejandro Dorenbaum: Innovator in Cholestasis Treatment
Introduction
Alejandro Dorenbaum is a prominent inventor based in Mill Valley, CA (US). He has made significant contributions to the field of medicine, particularly in the treatment of liver diseases. With a total of 12 patents to his name, Dorenbaum's work has the potential to impact many lives.
Latest Patents
Dorenbaum's latest patents focus on innovative methods for treating cholestasis. These methods involve administering an Apical Sodium-dependent Bile Acid Transporter (ASBTI) to subjects suffering from liver disease. Specifically, the invention details administering an ASBTI at a dose of at least 10 μg/kg/day to effectively treat cholestasis.
Career Highlights
Throughout his career, Dorenbaum has worked with notable companies such as BioMarin Pharmaceutical Inc. and Mirum Pharmaceuticals, Inc. His experience in these organizations has allowed him to develop and refine his innovative approaches to medical treatment.
Collaborations
Dorenbaum has collaborated with esteemed colleagues, including Daniel I Oppenheimer and Emil D Kakkis. These partnerships have further enhanced his research and development efforts in the medical field.
Conclusion
Alejandro Dorenbaum is a dedicated inventor whose work in treating cholestasis showcases his commitment to advancing medical science. His innovative methods and collaborations highlight the importance of teamwork in achieving breakthroughs in healthcare.